
TNDM Stock Forecast & Price Target
TNDM Analyst Ratings
Bulls say
Tandem Diabetes Care is a solid long-term investment as they have a strong presence in the insulin pump market, are shifting towards the pharmacy channel for more sustained revenue, and have a new product launch planned for the second half of the year. With plans to achieve significant market share and impressive growth and profitability targets, TNDM's focus on automated insulin delivery and transition to a Pay/Go model have the potential for long-term success, despite potential risks.
Bears say
Tandem Diabetes Care is a company with a narrow focus on designing and selling insulin pumps mainly in the US, accounting for the majority of its revenue. However, the pumps only account for half of its total sales and the company's profitability has been impacted by headwinds in new patient growth. Despite growth potential from new products and a potential pharmacy strategy, a negative financial outlook remains due to uncertainties around market positioning and potential upside in revenue and profitability from these efforts.
This aggregate rating is based on analysts' research of Tandem Diabetes Care and is not a guaranteed prediction by Public.com or investment advice.
TNDM Analyst Forecast & Price Prediction
Start investing in TNDM
Order type
Buy in
Order amount
Est. shares
0 shares